Red marrow dose measurement in phantom for tele-irradiation of the nasopharynx by cobalt-60 unit.
This investigation is to study red marrow dose measurement for the 60Co gamma-ray treatment of nasopharyngeal carcinoma with the aid of Rando phantom. The energy of scattered radiation in space and in tissue was investigated by means of half-value layers with thermoluminescent dosimeters. Other related factors such as field size, SSD, and orientation of primary beams were also investigated. In the non-metastases cases, the red marrow dose is 26 +/- 6 rads which is about 0.40% tumor dose excluding the marrow at the NPC site. For the metastases cases, the red marrow dose is still about 0.40% tumor dose. If the red marrow at the NPC site is included, the red marrow dose is about 14.5% tumor dose for both non-metastases and metastases cases.
D001853:Bone Marrow / Q000528:radiation effects*; D003037:Cobalt Radioisotopes / Q000008:administration & dosage*; D006801:Humans; D008961:Models, Structural; D009303:Nasopharyngeal Neoplasms / Q000532:radiotherapy*; D011867:Radioisotope Teletherapy; D011879:Radiotherapy Dosage; D013819:Thermoluminescent Dosimetry
D003037:Cobalt Radioisotopes